# CRISPR Therapeutics

**Canonical:** https://apis.io/providers/crispr-therapeutics/  
**Website:** https://www.crisprtx.com  
**APIs profiled:** 0

CRISPR Therapeutics (NASDAQ: CRSP) is a clinical-stage biotechnology company founded in 2013 and headquartered in Zug, Switzerland, with US operations in Boston, Massachusetts. Co-founded by CRISPR/Cas9 pioneer Emmanuelle Charpentier, the company develops transformative gene-based medicines for serious human diseases. Its programs span hemoglobinopathies, immuno-oncology, regenerative medicine, and in-vivo editing; its lead therapy CASGEVY (exagamglogene autotemcel), developed with Vertex Pharmaceuticals, is the first approved CRISPR/Cas9 gene-editing treatment for sickle cell disease and transfusion-dependent beta thalassemia. This is a corporate/investor web presence with no public developer program or API surface.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Crispr Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Life Sciences, Biotechnology, Gene Editing, CRISPR, Genomics, Pharmaceuticals

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/crispr-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.